Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher shares fell 1.8% Monday after a regulatory filing showed COO Michel Lagarde and EVP Frederick M. Lowery will depart in the first quarter. The company announced new AI-focused partnerships with TetraScience and Nvidia. Investors await Tuesday’s J.P. Morgan Healthcare Conference and the Jan. 29 earnings report for further signals on demand.
Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin shares rose $2.70 to $545.62 Monday as investors moved into defense stocks ahead of Tuesday’s CPI report and amid market volatility. Gains followed threats from the Trump administration to indict Fed Chair Jerome Powell and a proposal to cap credit card interest rates, which pressured financial stocks. Gold and defense shares rallied after Trump floated seizing Greenland. Lockheed reports Q4 earnings Jan. 29.
AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

Visa shares fell 1.6% to $344.25 by early afternoon Monday after President Trump proposed a one-year 10% cap on credit-card interest rates. Mastercard dropped 1.8%, American Express 4.2%. Analysts said such a cap would require Congressional approval, but the announcement increased volatility in card-related stocks. Traders are watching upcoming bank earnings and Tuesday’s CPI for further signals on consumer credit.
12 January 2026
IREN stock jumps nearly 9% today as Bernstein tags Nasdaq’s IREN a ‘top AI pick’

IREN stock jumps nearly 9% today as Bernstein tags Nasdaq’s IREN a ‘top AI pick’

IREN Limited shares surged 9% to $50.05 by midday Monday, outpacing other U.S.-listed bitcoin miners. The rally followed Bernstein analyst Gautam Chhugani naming IREN his “top AI pick” and setting a $150,000 bitcoin target for 2026. About 29.2 million shares traded after Friday’s close. Investors are watching Tuesday’s U.S. inflation data for further market direction.
12 January 2026
Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Nvidia and Eli Lilly will invest up to $1 billion in a Bay Area AI drug discovery lab over five years, sending Nvidia shares up 0.8% to $186.37 and Lilly up 0.2% to $1,066.14. AMD, Broadcom, and TSMC also rose as AI-focused stocks lifted the Nasdaq. TSMC reports earnings Jan. 15, with analysts expecting a 27% Q4 profit jump on AI chip demand. Nvidia’s next earnings are due Feb. 25.
Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin rose 0.3% to $91,147 Monday as Coinbase and Marathon Digital shares also gained. Fed Chair Jerome Powell confirmed the Justice Department served the central bank with grand jury subpoenas, sending the dollar lower and gold to a record above $4,600 an ounce. Strategy bought 13,627 bitcoin last week, bringing its holdings to 687,410. Traders await Tuesday’s U.S. CPI report and the Fed’s Jan. 27-28 meeting.
1 231 232 233 234 235 607

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop